Swanson L, Jungers S, Varghese R, Cullen K, Evans M, Nielson J
J Vis. 2024; 24(12):5.
PMID: 39499526
PMC: 11540033.
DOI: 10.1167/jov.24.12.5.
Volkov V, Lobanov A, Voronkov M, Baygildiev T, Misin V, Tsivileva O
Antioxidants (Basel). 2023; 12(8).
PMID: 37627525
PMC: 10451219.
DOI: 10.3390/antiox12081530.
Friesen P
Transcult Psychiatry. 2022; 59(5):592-609.
PMID: 36300247
PMC: 9660273.
DOI: 10.1177/13634615221129116.
Barker S
Psychopharmacology (Berl). 2022; 239(6):1749-1763.
PMID: 35064294
PMC: 8782705.
DOI: 10.1007/s00213-022-06065-0.
Uthaug M, Davis A, Haas T, Davis D, Dolan S, Lancelotta R
J Psychopharmacol. 2021; 36(3):309-320.
PMID: 33949246
PMC: 8902264.
DOI: 10.1177/02698811211013583.
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.
Barker S
Front Neurosci. 2018; 12:536.
PMID: 30127713
PMC: 6088236.
DOI: 10.3389/fnins.2018.00536.
DNA Methylation in Animal Models of Psychosis.
Grayson D, Guidotti A
Prog Mol Biol Transl Sci. 2018; 157:105-132.
PMID: 29933947
PMC: 7939130.
DOI: 10.1016/bs.pmbts.2017.12.012.
Indolethylamine--methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous ,-dimethyltryptamine.
Dean J
Front Neurosci. 2018; 12:232.
PMID: 29740267
PMC: 5924808.
DOI: 10.3389/fnins.2018.00232.
Unifying Theories of Psychedelic Drug Effects.
Swanson L
Front Pharmacol. 2018; 9:172.
PMID: 29568270
PMC: 5853825.
DOI: 10.3389/fphar.2018.00172.
Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.
Alachkar A, Wang L, Yoshimura R, Hamzeh A, Wang Z, Sanathara N
Mol Psychiatry. 2017; 23(2):282-294.
PMID: 28809400
PMC: 6432924.
DOI: 10.1038/mp.2017.164.
Potential drug targets and treatment of schizophrenia.
Kumar A, Yadav M, Parle M, Dhingra S, Dhull D
Inflammopharmacology. 2017; 25(3):277-292.
PMID: 28353125
DOI: 10.1007/s10787-017-0340-5.
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
De Gregorio D, Comai S, Posa L, Gobbi G
Int J Mol Sci. 2016; 17(11).
PMID: 27886063
PMC: 5133947.
DOI: 10.3390/ijms17111953.
Neuropharmacology of N,N-dimethyltryptamine.
Carbonaro T, Gatch M
Brain Res Bull. 2016; 126(Pt 1):74-88.
PMID: 27126737
PMC: 5048497.
DOI: 10.1016/j.brainresbull.2016.04.016.
A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity.
Wang L, Alachkar A, Sanathara N, Belluzzi J, Wang Z, Civelli O
Int J Neuropsychopharmacol. 2015; 18(12).
PMID: 25991655
PMC: 4675974.
DOI: 10.1093/ijnp/pyv054.
On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
Grammenos D, Barker S
J Neural Transm (Vienna). 2014; 122(6):733-9.
PMID: 25362533
DOI: 10.1007/s00702-014-1329-5.
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.
Arroll M, Wilder L, Neil J
Nutr J. 2014; 13:91.
PMID: 25228271
PMC: 4171568.
DOI: 10.1186/1475-2891-13-91.
Serotonergic hallucinogens as translational models relevant to schizophrenia.
Halberstadt A, Geyer M
Int J Neuropsychopharmacol. 2013; 16(10):2165-80.
PMID: 23942028
PMC: 3928979.
DOI: 10.1017/S1461145713000722.
Correlation between psychopathology and urinary steroid and biogenic amine metabolites in male schizophrenics.
Ghosh A, Varma V, Amma M
Indian J Psychiatry. 2011; 23(4):298-303.
PMID: 22064757
PMC: 3012898.
The pink spot.
Ridges A, Bourdillon R
Proc R Soc Med. 2010; 60(6):555-7.
PMID: 20918970
PMC: 1901867.
The Biochemistry of Mental Disease.
Sourkes T
Can Med Assoc J. 2010; 85(9):487-90.
PMID: 20326876
PMC: 1848322.
